Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy plus Cetuximab after TPF in Larynx Cancer
NCT00765011Phase 2Completed
- Start
- Oct 2008
- Primary completion
- Feb 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in laryngeal squamous cell carcinoma (LSCC). Started Oct 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
laryngeal squamous cell carcinoma (LSCC)
Beyond the preview
Go deeper on NCT00765011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765011.